P-glycoprotein does not actively transport nicotine and cotinine

Addiction Biology

Volumn 10, Issue 2, 2005, Pages 127-129

  Wang, Jun Sheng ^a   Markowitz, John S ^b   Donovan, Jennifer L ^a   DeVane, C Lindsay ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; COTININE; GLYCOPROTEIN P; NICOTINE; VERAPAMIL;

ABCB1 GENE; ACTIVE TRANSPORT; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; CONCENTRATION RESPONSE; DISEASE MARKER; GENE; HUMAN; OXIDATIVE STRESS; PLACENTA; PRIORITY JOURNAL; PROTEIN TRANSPORT; SMOKING; STATISTICAL SIGNIFICANCE;

ADENOSINE TRIPHOSPHATASES; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; CELL MEMBRANE; COTININE; HUMANS; NICOTINE; P-GLYCOPROTEIN; VERAPAMIL;

EID: 22144438684     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210500122995     Document Type: Article

References (11)

1. Boulton DW, DeVane CL, Liston HL, Markowitz JS. In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci 2002;31:163-9.
2. Fukada A, Saito H, Inui K. Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2. J Pharmacol Exp Ther 2002;302:532-8.
3. Gaertner LS, Murray CL, Morris CE. Transepithelial transport of nicotine and vinblastine in isolated malpighian tubules of the tobacco hornworm (Manduca sexta) suggests a P-glycoprotein-like mechanism. J Exp Biol 1998;201:2637-45.
4. Hoffmeyer S, Burk O, von Richter O et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-8.
5. Ilback NG, Stalhandske T. Nicotine accumulation in the mouse brain is age-dependent and is quantitatively different in various segments. Toxicol Lett 2003;143:175-84.
6. Keyler DE, Shoeman D, LeSage MG, Calvin AD, Pentel PR. Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats. J Pharmacol Exp Ther 2003;305:587-92.
7. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Del Rev 2003;55:3-29.
8. Tricker AR. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 2003;183:151-73.
9. Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL. The brain entry of risperidone and 9-hydroxyrisperidone are greatly limited by P-glycoprotein. Int J Neuropsychopharmacol 2004;7:491-7.
10. Wang JS, Taylor R, Runa Y, Donovan LJ, Markowitz SJ, DeVane CL. Olanzapine penetration inot brain is greater in transgenic mdr1a p-glycoprotein deficient mice than FVB1 (wild type) animals. Neuropsychopharmacology 2004;29:551-7.
11. Zevin S, Schaner ME, Giacomini KM. Nicotine transport in a human choriocarcinoma cell line (JAR). J Pharm Sci 1998;87:702-6.